Pacific Biosciences Of California | PACB - Eigenkapital Und Reserven

Aktienkurs
1.40
Täglich Wechseln
0.01 0.36%
Monatlich
-14.42%
Jährlich
6.49%
Q1 Prognose
1.29




Eigenkapital Und Reserven Veränderung Datum
Agilent USD 6.91B 167M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Danaher USD 52.53B 1.46B 2025-12
General Electric Aerospace USD 18.9B 86M 2025-12
Illumina USD 2.72B 342M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
Pacific Biosciences Of California USD 5.35M 30.74M 2025-12
Quidel USD 1.92B 115.9M 2025-12
Revvity USD 7.38B 180.27M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Standard Biotools USD 424.29M 24.63M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Waters USD 2.56B 230.55M 2025-12